Kristin Yarema Insider Profile
4 Followers
Kristin Yarema, CEO, Director at ImageneBio, holds 493.70K shares in ImageneBio (Ticker: IMA), holds 0.00 shares in Poseida Therapeutics (Ticker: PSTX), holds 171.41K shares in Atara Biotherapeutics (Ticker: ATRA).
Kristin Yarema has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kristin Yarema holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Kristin Yarema
Kristin Yarema's Trading History
ImageneBio
Aug 17, 2026
CEO, Director
Uninformative Buy
―
$2.26M
Atara Biotherapeutics
Mar 03, 2022
CCO
Uninformative Buy
―
$1.45M
Poseida Therapeutics
Jan 08, 2025
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Kristin Yarema's performance on stock
You May Also Like
Kristin Yarema insider profile FAQ
What is the percentage of profitable transactions made by Kristin Yarema?
The percentage of profitable transactions made by Kristin Yarema is ―.
What is the average return per transaction made by Kristin Yarema?
The average return per transaction made by Kristin Yarema is ―.
What stocks does Kristin Yarema hold?
Kristin Yarema holds: IMA, ATRA, PSTX stocks.
What was Kristin Yarema’s latest transaction?
Kristin Yarema latest transaction was an Uninformative Buy of ―.
What was Kristin Yarema's most profitable transaction?
Kristin Yarema’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Kristin Yarema's role in ImageneBio?
Kristin Yarema's role in ImageneBio is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.